Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis-Reference-Cited by-同舟云学术

Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis

Published:2018-12 Issue:12 Volume:16 Page:1954-1963.e3
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Jang Jeong Won,Choi Jong Young,Kim Young Seok,Yoo Jeong-Ju^ORCID,Woo Hyun Young,Choi Sung Kyu,Jun Chung Hwan,Lee Chang Hyeong,Sohn Joo Hyun,Tak Won Young,Lee Yu Rim,Han Kwang-Hyub

Funder

Ministry of Health and Welfare, Republic of Korea

Catholic Research Coordinating Center of the Korea Health 21 R&D Project

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference17 articles.

1. Treatment of hepatitis B in decompensated liver cirrhosis;Guan;Int J Hepatol,2011

2. Hepatitis B virus-related cirrhosis: natural history and treatment;Chu;Semin Liver Dis,2006

3. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver;de Jongh;Gastroenterology,1992

4. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis;Fattovich;Hepatology,1995

5. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load;Iloeje;Gastroenterology,2006

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study;The Lancet Gastroenterology & Hepatology;2024-08

2. Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis;JHEP Reports;2024-07

3. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B;Journal of Gastroenterology and Hepatology;2024-05

4. The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis;Insights into Imaging;2024-02-27

5. Multiple Low-level Viremia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients during Antiviral Therapy;2024-01-23